MedTrace Logo

International Rare Brain Tumor Registry

NCT05697874 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5800

Last updated 2026-03-31

No results posted yet for this study

Summary

The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.

Conditions

  • Astroblastoma
  • BCOR ITD Sarcoma
  • CNS Sarcoma
  • Unclassified Tumor, Malignant

Sponsors & Collaborators

  • Children's National Research Institute

    lead OTHER

Principal Investigators

Eligibility

Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2033-12-31
Completion
2033-12-31

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697874 on ClinicalTrials.gov